New survey data show a strong patient preference for fully remote clinical trials, underscoring how convenience, intuitive technology, and FDA-cleared digital tools are reshaping enrollment and ...

New Excel COPILOT Function tutorial with real world use cases. 👉 Take our AI for Business & Finance Course: 🆓 DOWNLOAD Free ...

Echoing President Donald Trump’s call to accelerate medical innovation, Food and Drug Administration (FDA) Commissioner Marty Makary announced that the agency will no longer block companies from ...

The FDA issued an RFI seeking venture capital input on a new contract model to connect portfolio companies directly with ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

The U.S. FDA’s final guidance for clinical trial inspections conducted under the bioresearch monitoring (BiMo) program seems to deviate little if at all from the 2024 draft, but that is precisely the ...

Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. Exactly a month after it announced the removal of black box warning labels on estrogen therapy products ...

Nearly 4 million Medicare-eligible Americans face heightened risk of disrupted medication access as restructuring efforts by the U.S. Postal Service slow mail delivery in rural and underserved ...

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. We’re entering a new era of prescription drug access. The local ...

Dec 11 (Reuters) - EU Council and Parliament negotiators have reached a provisional "pharma package" deal to modernize medicine rules, speed patient access and bolster competitiveness, the Council ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...